Zobrazeno 1 - 10
of 240
pro vyhledávání: ''
Autor:
Maximilian Gassenmaier, Narges Soltanpour, Laura Held, Gisela Metzler, Amir S. Yazdi, Ines B. Brecht, Dominik T. Schneider, Rudolf Stadler, Claus Garbe, Jürgen Bauer
Publikováno v:
European journal of cancer (Oxford, England : 1990). 163
Histological classification of atypical spitzoid tumours (ASTs) is unreliable, and categorisation of these lesions into benign and malignant is poorly reproducible. Here, we classified ASTs based on histology and chromosomal aberrations and explored
Publikováno v:
European Journal of Cancer
Background Efficacy and safety data of COVID-19 vaccines among cancer populations have been limited; however, preliminary data from recent studies have emerged regarding their immunogenicity and safety in this population. In this review, we examined
Autor:
Kirsten B. Goldberg, Thomas U. Marron, Yutao Gong, Chieh J. Lee, Celina Ang, Pallavi S. Mishra-Kalyani, Tiziana Pressiani, Thoetchai Peeraphatdit, Lola Fashoyin-Aje, Anushi Bulumulle, Elad Sharon, Mahvish Muzaffar, Alessio Cortellini, Pei Chang Lee, Ahmed Kaseb, David J. Pinato, Steven Lemery, Uqba Khan, Anwaar Saeed, Sonal Paul, Yinghong Wang, Yehia I. Abugabal, Bo Yu, Tomi Jun, Sirish Dharmapuri, Nicola Personeni, Lorenza Rimassa, Antonio D'Alessio, Guo Wei, Marc R. Theoret, Musharraf Navaid, Anuhya Gampa, Richard Pazdur, Hannah Hildebrand, Abdul Rafeh Naqash, Neil Nimkar, Yi Hsiang Huang, David Szafron, Julie A. Schneider, Lorraine Pelosof, Dominik Bettinger, Anjana Pillai
Publikováno v:
European journal of cancer (Oxford, England : 1990). 157
Purpose The development of treatment-related adverse events (trAE) correlates favorably with clinical outcomes in multiple studies of patients receiving immune checkpoint inhibitors (ICI); however, this relationship is undefined in patients with hepa
Autor:
Tadeusz Dyba, M Bettio, Francesco Giusti, Giorgia Randi, Freddie Bray, Luciana Neamtiu, M. Flego, Jacques Ferlay, Anna Gavin, Nadya Dimitrova, N. Nicholson, Carmen Martos, Raquel Negrao Carvalho
Publikováno v:
European Journal of Cancer
Introduction Europe is an important focus for compiling accurate and up-to-date world cancer statistics owing to its large share of the world's total cancer burden. This article presents incidence and mortality estimates for 25 major cancers across 4
Autor:
Che-Jui Lee, Michael G Leahy, Tomasz Switaj, Maria Debiec-Rychter, Sandra J. Strauss, Axelle Nzokirantevye, Anouk Neven, Bernd Kasper, Frank M. Speetjens, Antoine Italiano, Michaela Kubickova, Veit Bücklein, Raf Sciot, Agnieszka Wozniak, Jean-Yves Blay, Patrick Schöffski, Silvia Stacchiotti, Nicolas Isambert
Publikováno v:
European Journal of Cancer, 156, 12-23. ELSEVIER SCI LTD
Purpose: European Organisation for Research and Treatment of Cancer (EORTC) 90101 (CREATE) was a prospective, multicentric, non-randomised, open-label phase II bas-ket trial to assess the efficacy and safety of crizotinib in patients with different t
Autor:
Capucine Baldini, Christophe Massard, Anne-Laure Voisin, Aurélien Marabelle, A. Laparra, Jean-Marie Michot, François-Xavier Danlos, Sabine Messayke, Patricia Romano-Martin, Valentine Ruste, Olivier Lambotte, Stéphane Champiat, Vincent Goldschmidt, Salim Laghouati
Publikováno v:
European journal of cancer (Oxford, England : 1990). 158
Background Immune-related adverse events (irAEs) remain generally unpredictable, and severe irAEs remain challenging to detect early and manage. Very severe (grade IV–V) irAEs have not been extensively characterised in prospective studies, and thei
Autor:
Lukas Flatz, Teresa Amaral, Ulrike Leiter, David C. Whiteman, Ulrike Keim, Alexander Katalinic, Claus Garbe, Bernd Hollezcek, Sara Gandini, Peter Martus
Publikováno v:
European journal of cancer (Oxford, England : 1990). 152
Objectives Cutaneous melanoma (CM) and keratinocyte cancer (KC) cause considerable morbidity and mortality. We analysed long-term trends of CM and KC in different white populations. Material and methods Age-standardised (European Standard Population
Autor:
Wim J. E. Tissing, Martha A. Grootenhuis, Dorine Bresters, L.M.E. van Erp, A C de Vries, Cécile M. Ronckers, A.L.L.F. van der Kooi, H. J. H. van der Pal, M. van den Berg, M. van Gorp, Marloes Louwerens, Jacqueline J. Loonen, L. C. M. Kremer, Heleen Maurice-Stam, E. van Dulmen-den Broeder, M. Van der Heiden-van der Loo, Birgitta Versluys, M.M. van den Heuvel-Eibrink
Publikováno v:
European Journal of Cancer, 152, 204-214. Pergamon
European Journal of Cancer, 152, 204-214. ELSEVIER SCI LTD
European Journal of Cancer, 152, 204-214
European Journal of Cancer, 152, 204-214. Elsevier Ltd.
van Erp, L M E, Maurice-Stam, H, Kremer, L C M, Tissing, W J E, van der Pal, H J H, de Vries, A C H, van den Heuvel-Eibrink, M M, Versluys, B A B, Loonen, J J, Bresters, D, Louwerens, M, van der Heiden-van der Loo, M, van den Berg, M H, Ronckers, C M, van der Kooi, A L L F, van Gorp, M, van Dulmen-den Broeder, E & Grootenhuis, M A 2021, ' Health-related quality of life in Dutch adult survivors of childhood cancer: A nation-wide cohort study ', European Journal of Cancer, vol. 152, pp. 204-214 . https://doi.org/10.1016/j.ejca.2021.04.033
European Journal of Cancer, 152, pp. 204-214
European Journal of Cancer, 152, 204-214. ELSEVIER SCI LTD
European Journal of Cancer, 152, 204-214
European Journal of Cancer, 152, 204-214. Elsevier Ltd.
van Erp, L M E, Maurice-Stam, H, Kremer, L C M, Tissing, W J E, van der Pal, H J H, de Vries, A C H, van den Heuvel-Eibrink, M M, Versluys, B A B, Loonen, J J, Bresters, D, Louwerens, M, van der Heiden-van der Loo, M, van den Berg, M H, Ronckers, C M, van der Kooi, A L L F, van Gorp, M, van Dulmen-den Broeder, E & Grootenhuis, M A 2021, ' Health-related quality of life in Dutch adult survivors of childhood cancer: A nation-wide cohort study ', European Journal of Cancer, vol. 152, pp. 204-214 . https://doi.org/10.1016/j.ejca.2021.04.033
European Journal of Cancer, 152, pp. 204-214
Aim: To investigate the health-related quality of life (HRQOL) of Dutch adult childhood cancer survivors (CCS) and to identify risk factors of impaired HRQOL.Methods: Adult CCS (age >18, diagnosed = 5 years since diagnosis) from the Dutch LATER regis
Autor:
Julius Moratin, Subramania Iyer, Christian Freudlsperger, Linda Feeley, Ruta Gupta, Davide Mattavelli, Krishnakumar Thankappan, Carsten E. Palme, Kan Gao, Alfons J. M. Balm, Tsu-Hui Hubert Low, Cesare Piazza, Therese Ovesen, Chris Milross, Mischa de Ridder, Jonathan R. Clark, Yogesh Dokhe, Patrick Sheahan, Narayana Subramaniam, Sana D. Karam, Susanne Wiegand, Deepak Balasubramanian, Maria Pedersen, Christian Mirian, Thomas A. Gerds, Lasse Rehné Jensen
Publikováno v:
European journal of cancer (Oxford, England : 1990). 150
Background We aimed to compare the predictive performance of pN-categories in oral squamous cell carcinoma (OSCC) encompassing the most recent 8th edition (TNM8), its predecessor (TNM7), and a newly proposed algorithm (pN-N+), which classifies patien
Autor:
Zhen Liu, Huilai Zhang, Yan Sun, Shanzhi Gu, Dan Liu, Liling Zhang, Jun Lv, Ping Lu, Jifang Gong, Jianming Guo, Chunguang Ma, Lin Shen, Wang Xiang, Peijian Peng, Qi Li, Jianji Pan, Hang Su, Yuqin Song, Xianli Yin, Chongyuan Xu, Bangwei Cao, Li Chen, Dingwei Ye, Weiqing Han, Ou Jiang, Lulin Ma, Yongsheng Jiang, Guojun Zhang, Haiying Dong, Feng Zhang, Junyuan Qi, Jianhua Chen, Li Wang, Yuxian Bai, Yi Ba, Weiwei Ouyang, Siyang Wang, Y Guo
Publikováno v:
European journal of cancer (Oxford, England : 1990). 148
Background GLS-010, a novel engineered fully human immunoglobin G4 monoclonal antibody, can specially block the PD-1/PD-L1/2 axis and reactivate the antitumor immunity. Aim This phase Ia/Ib study was carried out to evaluate the safety, recommended ph